Publication:
Salbutamol in acute organophosphorus insecticide poisoning–a pilotdose-response phase II study

dc.contributor.authorFazle Rabbi Chowdhuryen_US
dc.contributor.authorMd Mustafezur Rahmanen_US
dc.contributor.authorParash Ullahen_US
dc.contributor.authorAbdul Mumith Ruhanen_US
dc.contributor.authorMd Shafiqul Barien_US
dc.contributor.authorM. M.Jahangir Alamen_US
dc.contributor.authorMd Moyeen Uddinen_US
dc.contributor.authorShomik Marufen_US
dc.contributor.authorMd Ismail Patwaryen_US
dc.contributor.authorMichael Eddlestonen_US
dc.contributor.otherUniversity of Peradeniyaen_US
dc.contributor.otherUniversity of Edinburghen_US
dc.contributor.otherDhaka Medical College and Hospitalen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherInternational Centre for Diarrhoeal Disease Research Bangladeshen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherBangabandhu Sheikh Mujib Medical Universityen_US
dc.contributor.otherSylhet MAG Osmani Medical Collegeen_US
dc.date.accessioned2019-08-28T06:48:43Z
dc.date.available2019-08-28T06:48:43Z
dc.date.issued2018-09-02en_US
dc.description.abstract© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Background: Treatment of acute organophosphorus (OP) insecticide poisoning is difficult, with many patients dying despite best care. Pre-clinical studies have shown benefit from salbutamol, possibly due speeding alveolar fluid clearance or reducing bronchoconstriction. In this small pilot dose-response study, we aimed to explore whether addition of nebulized salbutamol to standard care might improve resuscitation. Methods: We performed a single-blind phase II study comparing the effect of two different doses of nebulized salbutamol versus saline placebo, in addition to standard treatment. Primary outcome was oxygen saturations over the first 60 min of resuscitation; secondary outcomes included heart rate, incidence of dysrhythmias, time to ‘atropinization’, atropine dose required, and mortality. Result: Seventy-five patients were randomized to receive 5 mg (Salb5, n = 25) or 2.5mg (Salb2.5, n = 25) of salbutamol, or saline placebo (NoSalb, n = 25), by nebulizer. Oxygen saturations did not differ between groups over the first 60 min of resuscitation (median AUC NoSalb: 1376 [95% CI 1282 to 1470], Salb2.5: 1395 [1305 to 1486], Salb5: 1233 [1100 to 1367]; p =.9898). Heart rate was also similar across the three arms. Median time to full atropinization, and atropine dose required, were the same for all three arms (NoSalb 15.0 [10–16] min and 12.6 [8.0–13.4] mg, Salb2.5 15.0 [10–16] min and 12.6 [9.3–16.8] mg, and Salb5 15.0 [10–20] min and 12.6 [10.7–20.6] mg; p =.4805 and p =.1871, respectively). Three (12%) patients died in the Salb2.5 and Salb5 groups and two (8%) in the NoSalb group. Conclusion: This pilot study, within the limitations of its small size and variation between patients, found no apparent evidence that administration of nebulized salbutamol improved resuscitation of patients with acute OP insecticide self-poisoning. The data obtained provides a basis to design further studies to ultimately test the role of salbutamol in OP insecticide poisoning.en_US
dc.identifier.citationClinical Toxicology. Vol.56, No.9 (2018), 820-827en_US
dc.identifier.doi10.1080/15563650.2018.1440587en_US
dc.identifier.issn15569519en_US
dc.identifier.issn15563650en_US
dc.identifier.other2-s2.0-85042217956en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/47299
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042217956&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleSalbutamol in acute organophosphorus insecticide poisoning–a pilotdose-response phase II studyen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042217956&origin=inwarden_US

Files

Collections